STAANasdaqOphthalmic GoodsFiscal year ends January 2
STAAR SURGICAL CO
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 12, 2026
$21.88+0.61 (+2.87%)
Close on Oct 19, 2026
- Market cap
- $1.13B
- P/E (TTM)
- 312.6
- Dividend yield
- –
STAAR SURGICAL CO revenue by segment
By business segment
By product or service
By region
From the segment and revenue-disaggregation notes of Staar Surgical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.